Form 4 Tracker
Steven Pieper

Chief Financial Officer · 6 filings · Latest: Oct 1, 2026

Xeris Biopharma Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
XERS
Steven PieperChief Financial OfficerOct 1, 2026
Sale
$9.415,000$47.0K1,351,053
XERS
Steven PieperChief Financial OfficerSep 1, 2026
Sale
$8.505,000$42.5K1,356,053
XERS
Steven PieperChief Financial OfficerAug 12, 2026
Sale
$8.505,000$42.5K1,361,053
XERS
STEVEN PIEPER—Aug 12, 2026
Proposed Sale
$8.3920,000$167.8K—
XERS
Steven PieperChief Financial OfficerJul 7, 2026
Sale
$8.5227,600$235.3K1,366,053
XERS
Steven PieperChief Financial OfficerJul 6, 2026
Sale
$8.5017,400$147.9K1,393,653
XERS
STEVEN PIEPER—Jul 7, 2026
Proposed Sale
$8.3727,600$231.0K—
XERS
STEVEN PIEPER—Jul 6, 2026
Proposed Sale
$8.2817,400$144.1K—
XERS
Steven PieperChief Financial OfficerMar 5, 2026
Option Exercise
$4.7141,927$197.3K1,408,940